Martin Shkreli: This Week In Investing (19)

|
Includes: AVXS, CMCSA, DMTX, GILD, INVA, MYOK, REGN, SGMO, TEVA, WB, XNCR
by: Martin Shkreli

Summary

In this week's episode, Martin covers weakness in generic pharma

Is value-investing risk aversion?

"My worst public company investment ever"

"Why does Buffett recommend indexing and you don't?"

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.